/PRNewswire/ ALFASIGMA S.p.A. has signed an agreement to acquire the entire share capital of SOFAR S.p.A., an Italian pharmaceutical company with over half.
Alfasigma inaugurates the new Research & Development center in Pomezia named after its founder Marino Golinelli finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Alfasigma inaugurates the new Research & Development center in [ ] | Comunicati stampa CataniaOggi cataniaoggi.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cataniaoggi.it Daily Mail and Mail on Sunday newspapers.